AB Sciex launches data analysis software

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2013

Singapore: AB Sciex, a global leader in analytical technologies, has launched MasterView Software, a new software applic...Read more

LCT conducts first implant of regenerative therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...Read more

GSK melanoma phase III misses co-primary endpoint

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

Singapore: GlaxoSmithKline's (GSK) Dermai study, a phase III, randomized, blinded, placebo-controlled Mage-A3 cancer imm...Read more

Bayer cancer drug Stivarga gets Singapore nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

Singapore: The Health Sciences Authority (HSA) of Singapore has approved Bayer' Stivarga, the first oral targeted therap...Read more

Eye diseases cost upto $27bn to Europe

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2013

Singapore: European Forum Against Blindness (EFAB) has revealed the results of a six-country study which analyzed the ec...Read more

Gilead hepatitis drug to axe treatment time by half

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2013

Singapore: Gilead Sciences has submitted a New Drug Application (NDA) to the US FDA for approval of sofosbuvir, a once-d...Read more

Gilead leukemia study gets complete response

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2013

Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...Read more

Advinus collaborates with P2D Bioscience for ADHD

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2012

Bangalore: Advinus Therapeutics, a Bangalore-based drug discovery and development company, and P2D Bioscience, a CNS-foc...Read more

All you need to know about Glivec

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

What is Glivec?Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, ...Read more

Cytomegalovirus treatments to improve

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generall...Read more

Sol-Gel to treat rosacea using acne drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

Singapore: Israel-based Sol-Gel Technologies achieved positive results for a phase II trial in the US targeting mild-to-...Read more

Phyto-pharmaceuticals to hit Indian markets soon

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

Singapore: The Indian Ministry of Health and Family Welfare has notified the draft rules on a new domain of medicines ca...Read more

Novartis' thalassemia drug Exjade get EMA nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...Read more

FDA scraps advisory committee on Merck's drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

Singapore: The US FDA has cancelled an advisory committee meeting that was scheduled to be held on July 18, 2013, in ord...Read more

Patrys cancer drug gives hope to patients

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...Read more

Agilent, SomaLogic to expand proteomic tech

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2013

Singapore: Agilent Technologies and US-based SomaLogic have entered into an agreement to expand access to SomaLogic's un...Read more

Boehringer and Lilly get FDA nod for add-on insulin drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2012

Singapore: Boehringer Ingelheim and Eli Lilly and Company received approved from the US FDA for a supplemental new drug ...Read more

Regeneron, Sanofi brain drug has side effects: US FDA

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

Singapore: Regeneron Pharmaceuticals and Sanofi have been asked by the US FDA to assess potential neurocognitive side ef...Read more